Mobile App Click here to download our Mobile App for iOS or Android
Not a member? Sign up for free!

The Aftermath Of Suicide: What Can Be Done & How Should We Talk About It?

Webinar | September 10, 2018 12:00 pm to 1:00 pm ET
You must be logged in to register for PsychU events. Log In

Not a member? Sign up for free!

Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration.
Sign up today for instant access to all PsychU offerings. Membership is free!

Join PsychU


Virtual Forum: The Aftermath Of Suicide: What Can Be Done & How Should We Talk About It?

Location: Online Via

Suicide rates are on the rise nationally, with recent Centers for Disease Control statistics indicating a 28% rise in suicide-related deaths between 1999-2016. Suicide is currently the tenth leading cause of death in the United States overall, and the second leading cause of death for individuals between 10 and 34 years of age, leaving more than half of the US population experiencing its direct impact. Although assessment, prevention, and intervention strategies are crucial for predicting and preventing suicide, postvention / exposure practices are paramount to facilitating bereavement and healing in those impacted by suicide. Media coverage, as well as our own suicide-related language, can have a significant effect on either mitigating grief or sensationalizing the loss for family, friends, loved ones, and society at large.

In this Virtual Forum, Dr. Julie Cerel & Dr. Jill Harkavy-Friedman will discuss what happens after a patient, family member, or friend takes their life by suicide, and how promoting postvention activities is essential for various stakeholders in the community, including mental health professionals. Speakers will also cover the critical components of postvention / exposure research, and appropriate suicide language relevant to health care professionals and the lay public.

If you or someone you know is in crisis, please contact the Suicide Prevention Hotline / Lifeline at 1-800-273-TALK (8255), or text the Crisis Text Line at 741-741.

Speakers are paid consultants to Otsuka Pharmaceutical Development & Commercialization, Inc.

View Flyer (PDF)

Event Speakers

Julie Cerel, PhD
Featured Speaker

Julie Cerel, PhD, currently serves as the President of the American Association of Suicidology (AAS), as a Professor in the College of Social Work at the University of Kentucky, as a member of the Editorial Board for Suicide & Life Threatening Behavior, and as a licensed clinical psychologist.

She is the author of over 65 academic publications, with her work being funded by the Military Suicide Research Consortium from the U.S. Department of Defense, the Centers for Disease Control and Prevention (CDC), the Substance Abuse and Mental Health Services Administration (SAMHSA), the Suicide Prevention Action Network USA (SPAN-US), and the American Foundation for Suicide Prevention (AFSP). Her research has focused on suicide bereavement, suicide attempt survivors, and suicide prevention.

Dr. Cerel received her PhD in Clinical Psychology from the Ohio State University.

Jill Harkavy-Friedman, PhD
Featured Speaker

Jill Harkavy-Friedman, PhD, currently serves as Vice President of Research at the American Foundation of Suicide Prevention (AFSP), and an Associate Professor at Columbia University. She represents AFSP nationally and internationally with organizations including the National Institutes on Mental Health (NIMH), the Substance Abuse & Mental Health Services Administration (SAMHSA), and Suicide Research Summit.

She is the recipient of a suicide research grant from AFSP and NIMH, and oversees the AFSP research grant program. She has published over 100 peer reviewed publications. She has been working as a clinician and researcher, translating research in to practice for suicide prevention for over 30 years.

Dr. Harkavy-Friedman received her PhD from University of Florida, and completed an internship at Yale-New Haven Hospital.

Stephen Murray, PharmD, MBA

Stephen Murray, PharmD, MBA, currently serves as a Senior Medical Science Liasion for Otsuka Pharmaceutical Development & Commercialization, Inc.

The registration for this event is now closed. For more information about our live event registration process, please read the Live Event Eligibility Requirements